3-(hydroxymethyl)-5-[4-(3-hydroxy-3-methylbutoxy)phenyl]-7-pyridin-3-ylpyrrolo[2,3-d]pyrimidin-4-one
C23H24N4O4 — CID 167359918
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(hydroxymethyl)-5-[4-(3-hydroxy-3-methylbutoxy)phenyl]-7-pyridin-3-ylpyrrolo[2,3-d]pyrimidin-4-one
3-(hydroxymethyl)-5-[4-(3-hydroxy-3-methylbutoxy)phenyl]-7-pyridin-3-ylpyrrolo[2,3-d]pyrimidin-4-one (PubChem CID 167359918) has the molecular formula C23H24N4O4 and a molecular weight of 420.47 g/mol. Its IUPAC name is 3-(hydroxymethyl)-5-[4-(3-hydroxy-3-methylbutoxy)phenyl]-7-pyridin-3-ylpyrrolo[2,3-d]pyrimidin-4-one.
Molecular Properties
| Compound Name | 3-(hydroxymethyl)-5-[4-(3-hydroxy-3-methylbutoxy)phenyl]-7-pyridin-3-ylpyrrolo[2,3-d]pyrimidin-4-one |
|---|---|
| PubChem CID | 167359918 |
| Molecular Formula | C23H24N4O4 |
| Molecular Weight | 420.47 g/mol |
| Exact Mass | 420.18 |
| IUPAC Name | 3-(hydroxymethyl)-5-[4-(3-hydroxy-3-methylbutoxy)phenyl]-7-pyridin-3-ylpyrrolo[2,3-d]pyrimidin-4-one |
| SMILES | CC(C)(O)CCOc1ccc(-c2cn(-c3cccnc3)c3ncn(CO)c(=O)c23)cc1 |
| InChI | InChI=1S/C23H24N4O4/c1-23(2,30)9-11-31-18-7-5-16(6-8-18)19-13-27(17-4-3-10-24-12-17)21-20(19)22(29)26(15-28)14-25-21/h3-8,10,12-14,28,30H,9,11,15H2,1-2H3 |
| InChIKey | QWBKWIFKJVOOBU-UHFFFAOYSA-N |
| XLogP | 2.74 |
| TPSA | 102.40 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 420.47 |
| LogP ≤ 5 | 2.74 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167359918 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.